Chimera Investment Corp has a consensus price target of $8.4 based on the ratings of 5 analysts. The high is $16 issued by Keefe, Bruyette & Woods on August 8, 2024. The low is $5.5 issued by UBS on December 6, 2023. The 3 most-recent analyst ratings were released by Keefe, Bruyette & Woods, Keefe, Bruyette & Woods, and UBS on August 8, 2024, July 10, 2024, and December 6, 2023, respectively. With an average price target of $12.17 between Keefe, Bruyette & Woods, Keefe, Bruyette & Woods, and UBS, there's an implied -17.90% downside for Chimera Investment Corp from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Chimera Investment (NYSE:CIM) was reported by Keefe, Bruyette & Woods on August 8, 2024. The analyst firm set a price target for $16.00 expecting CIM to rise to within 12 months (a possible 7.74% upside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for Chimera Investment (NYSE:CIM) was provided by Keefe, Bruyette & Woods, and Chimera Investment maintained their market perform rating.
There is no last upgrade for Chimera Investment
There is no last downgrade for Chimera Investment.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chimera Investment, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chimera Investment was filed on August 8, 2024 so you should expect the next rating to be made available sometime around August 8, 2025.
While ratings are subjective and will change, the latest Chimera Investment (CIM) rating was a maintained with a price target of $15.00 to $16.00. The current price Chimera Investment (CIM) is trading at is $14.85, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.